WOLVERINE ASSET MANAGEMENT LLC - IRONWOOD PHARMACEUTICALS INC ownership

IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 250 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.84 and the average weighting 0.1%.

Quarter-by-quarter ownership
WOLVERINE ASSET MANAGEMENT LLC ownership history of IRONWOOD PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2021$14,000
+1300.0%
1,339
+1239.0%
0.00%
Q1 2020$1,000
-99.9%
100
-99.9%
0.00%
-100.0%
Q4 2019$1,108,000
+17.9%
83,300
-23.9%
0.01%
+8.3%
Q3 2019$940,000
+23400.0%
109,500
+27275.0%
0.01%
Q2 2019$4,000
-99.5%
400
-99.1%
0.00%
-100.0%
Q3 2018$795,000
-86.1%
43,100
-85.6%
0.01%
-87.8%
Q2 2018$5,737,000
+62.7%
300,100
+31.3%
0.07%
+60.9%
Q1 2018$3,527,000
+206.4%
228,600
+197.3%
0.05%
+318.2%
Q4 2017$1,151,000
+94.8%
76,900
+105.1%
0.01%
+83.3%
Q3 2017$591,000
+11.1%
37,500
+33.0%
0.01%
-14.3%
Q2 2017$532,000
-54.6%
28,200
-59.0%
0.01%
-61.1%
Q1 2017$1,173,000
-33.5%
68,800
-40.4%
0.02%
-21.7%
Q4 2016$1,765,000
-69.2%
115,500
-68.0%
0.02%
-73.3%
Q3 2016$5,737,000
-56.5%
361,300
-64.2%
0.09%
-57.0%
Q2 2016$13,190,000
+3690.2%
1,008,800
+17598.2%
0.20%
+1900.0%
Q1 2016$348,000
+3.3%
5,700
+89.2%
0.01%
+42.9%
Q4 2015$337,000
-57.8%
3,013
-5.7%
0.01%
-63.2%
Q3 2015$798,000
+107.3%
3,194
+68.6%
0.02%
+111.1%
Q2 2015$385,0001,8940.01%
Other shareholders
IRONWOOD PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Sarissa Capital Management LP 16,390,000$157,835,70021.26%
AlphaCentric Advisors LLC 292,500$2,816,7751.60%
Quantedge Capital Pte Ltd 179,900$1,732,4370.94%
Intrinsic Value Partners, LLC 50,355$484,9190.62%
Brown Capital Management 3,719,796$35,821,6350.55%
ARMISTICE CAPITAL, LLC 3,456,000$33,281,2800.51%
SummerHaven Investment Management, LLC 67,765$652,5770.48%
BRAIDWELL LP 1,348,099$12,982,1930.41%
AFFINITY INVESTMENT ADVISORS, LLC 50,733$488,5590.32%
EMC Capital Management 43,315$4170.31%
View complete list of IRONWOOD PHARMACEUTICALS INC shareholders